Skip to main content
Erschienen in: Journal of General Internal Medicine 5/2020

01.05.2020 | Original Research

Trends in Diabetes Management Among US Adults: 1999–2016

verfasst von: Michael Fang, PhD

Erschienen in: Journal of General Internal Medicine | Ausgabe 5/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

Updating national trends in diabetes management is important for identifying areas of progress and remaining gaps in diabetes care.

Objective

Evaluate trends in diabetes management.

Design

Three nationally representative, serial cross-sectional surveys (National Health and Nutrition Examination Survey [n = 5800], National Health Interview Survey [n = 48,519], and Behavioral Risk Factor Surveillance System [n = 741,497]) were used to estimate trends in diabetes management from 1999 to 2016.

Participants

Non-pregnant US adults (aged ≥ 18 years) diagnosed with diabetes.

Main Measures

American Diabetes Association’s general recommendations for glycemic and cardiovascular risk factor control, medication usage, physical activity, preventive practices, and dietary intake.

Key Results

From 1999 to 2016, the proportion of US adults with diabetes who attained glycemic control (HbA1c < 7.0%) followed a quadratic trend (49.6% in 1999–2004 to 58.6% in 2005–2010 to 55.8% in 2011–2016, P < 0.05 for trend). Control of blood pressure (< 140/90 mmHg) and lipids (LDL cholesterol < 100 mg/dl) increased by 6.6 and 18.7 percentage points, respectively (P < 0.05 for trends). The proportion that attained glycemic, blood pressure, and lipid control followed a quadratic trend (13.3% in 1999–2004 to 24.8% in 2005–2010 to 20.2% in 2011–2016, P < 0.05 for trend). Use of antidiabetic, antihypertensive, and statin medication among those who were eligible rose by 8.6, 5.0, and 24.0 percentage points, respectively (P < 0.05 for trends). Aerobic inactivity declined 7.1 percentage points, while adherence to aerobic activity (≥ 150 min/week) and resistance training (≥ 2 times/week) recommendations grew 3.4 and 3.2 percentage points, respectively (P < 0.05 for trends). Engagement in preventive practices (e.g., receipt of vaccinations) consistently increased for 6 out of 8 outcomes. However, the adherence to saturated fat (< 10% of total daily calories) and sodium (< 2300 mg/day) recommendations fell by 6.5 and 5.2 percentage points (P < 0.05 for trends).

Conclusions

Despite notable improvements, declines in glycemic control and adherence to dietary recommendations may be growing challenges in diabetes care.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Menke A, Casagrande S, Geiss L, Cowie CC. Prevalence of and trends in diabetes among adults in the United States, 1988-2012. JAMA. 2015;314(10):1021–1029.CrossRef Menke A, Casagrande S, Geiss L, Cowie CC. Prevalence of and trends in diabetes among adults in the United States, 1988-2012. JAMA. 2015;314(10):1021–1029.CrossRef
2.
Zurück zum Zitat Geiss LS, Wang J, Cheng YJ, et al. Prevalence and incidence trends for diagnosed diabetes among adults aged 20 to 79 years, United States, 1980-2012. JAMA. 2014;312(12):1218–1226.CrossRef Geiss LS, Wang J, Cheng YJ, et al. Prevalence and incidence trends for diagnosed diabetes among adults aged 20 to 79 years, United States, 1980-2012. JAMA. 2014;312(12):1218–1226.CrossRef
3.
Zurück zum Zitat Selvin E, Parrinello CM, Sacks DB, Coresh J. Trends in Prevalence and Control of Diabetes in the United States, 1988–1994 and 1999–2010. Ann Intern Med. 2014;160(8):517–525.CrossRef Selvin E, Parrinello CM, Sacks DB, Coresh J. Trends in Prevalence and Control of Diabetes in the United States, 1988–1994 and 1999–2010. Ann Intern Med. 2014;160(8):517–525.CrossRef
4.
Zurück zum Zitat Fang M. Trends in the prevalence of diabetes among US Adults: 1999–2016. Am J Prev Med. 2018;55(4):497–505.CrossRef Fang M. Trends in the prevalence of diabetes among US Adults: 1999–2016. Am J Prev Med. 2018;55(4):497–505.CrossRef
5.
Zurück zum Zitat Fowler MJ. Microvascular and macrovascular complications of diabetes. Clin Diabetes. 2008;26(2):77–82.CrossRef Fowler MJ. Microvascular and macrovascular complications of diabetes. Clin Diabetes. 2008;26(2):77–82.CrossRef
6.
Zurück zum Zitat Zoungas S, Arima H, Gerstein HC, et al. Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials. Lancet Diabetes Endocrinol. 2017;5(6):431–437.CrossRef Zoungas S, Arima H, Gerstein HC, et al. Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials. Lancet Diabetes Endocrinol. 2017;5(6):431–437.CrossRef
7.
Zurück zum Zitat American Diabetes Association. American Diabetes Association Standards of Medical Care in Diabetes—2016. 2016;34(Supp 1):S1-S112. American Diabetes Association. American Diabetes Association Standards of Medical Care in Diabetes—2016. 2016;34(Supp 1):S1-S112.
8.
Zurück zum Zitat Ali MK, Bullard KM, Saaddine JB, Cowie CC, Imperatore G, Gregg EW. Achievement of goals in US diabetes care, 1999–2010. N Engl J Med. 2013;368(17):1613–1624.CrossRef Ali MK, Bullard KM, Saaddine JB, Cowie CC, Imperatore G, Gregg EW. Achievement of goals in US diabetes care, 1999–2010. N Engl J Med. 2013;368(17):1613–1624.CrossRef
9.
Zurück zum Zitat Casagrande SS, Fradkin JE, Saydah SH, Rust KF, Cowie CC. The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988–2010. Diabetes Care. 2013;36(8):2271–2279.CrossRef Casagrande SS, Fradkin JE, Saydah SH, Rust KF, Cowie CC. The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988–2010. Diabetes Care. 2013;36(8):2271–2279.CrossRef
10.
Zurück zum Zitat Carls G, Huynh J, Tuttle E, Yee J, Edelman SV. Achievement of glycated hemoglobin goals in the US remains unchanged through 2014. Diabetes Therapy. 2017;8(4):863–873.CrossRef Carls G, Huynh J, Tuttle E, Yee J, Edelman SV. Achievement of glycated hemoglobin goals in the US remains unchanged through 2014. Diabetes Therapy. 2017;8(4):863–873.CrossRef
11.
Zurück zum Zitat Kazemian P, Shebl FM, McCann N, Walensky RP, Wexler DJ. Evaluation of the cascade of diabetes care in the United States, 2005-2016. JAMA Intern Med. 2019;179(10):1376–1385.CrossRef Kazemian P, Shebl FM, McCann N, Walensky RP, Wexler DJ. Evaluation of the cascade of diabetes care in the United States, 2005-2016. JAMA Intern Med. 2019;179(10):1376–1385.CrossRef
12.
Zurück zum Zitat Mann DM, Woodward M, Ye F, Krousel-Wood M, Muntner P. Trends in medication use among US adults with diabetes mellitus: glycemic control at the expense of controlling cardiovascular risk factors. Arch Intern Med. 2009;169(18):1718–1725.CrossRef Mann DM, Woodward M, Ye F, Krousel-Wood M, Muntner P. Trends in medication use among US adults with diabetes mellitus: glycemic control at the expense of controlling cardiovascular risk factors. Arch Intern Med. 2009;169(18):1718–1725.CrossRef
13.
Zurück zum Zitat Alexander GC, Sehgal NL, Moloney RM, Stafford RS. National trends in treatment of type 2 diabetes mellitus, 1994-2007. Arch Intern Med. 2008;168(19):2088–2094.CrossRef Alexander GC, Sehgal NL, Moloney RM, Stafford RS. National trends in treatment of type 2 diabetes mellitus, 1994-2007. Arch Intern Med. 2008;168(19):2088–2094.CrossRef
14.
Zurück zum Zitat Centers for Disease Control and Prevention. Diabetes Report Card 2017. Atlanta, GA: Centers for Disease Control and Prevention, US Department of Health and Human Services; 2018. Centers for Disease Control and Prevention. Diabetes Report Card 2017. Atlanta, GA: Centers for Disease Control and Prevention, US Department of Health and Human Services; 2018.
15.
Zurück zum Zitat Casagrande S, Cowie C. Trends in dietary intake among adults with type 2 diabetes: NHANES 1988–2012. J Hum Nutr Diet. 2017;30(4):479–489.CrossRef Casagrande S, Cowie C. Trends in dietary intake among adults with type 2 diabetes: NHANES 1988–2012. J Hum Nutr Diet. 2017;30(4):479–489.CrossRef
16.
Zurück zum Zitat Zhao G, Ford E, Li C, Mokdad A. Compliance with physical activity recommendations in US adults with diabetes. Diabet Med. 2008;25(2):221–227.CrossRef Zhao G, Ford E, Li C, Mokdad A. Compliance with physical activity recommendations in US adults with diabetes. Diabet Med. 2008;25(2):221–227.CrossRef
17.
Zurück zum Zitat Oza-Frank R, Cheng YJ, Narayan KV, Gregg EW. Trends in nutrient intake among adults with diabetes in the United States: 1988-2004. J Acad Nutr Diet. 2009;109(7):1173–1178. Oza-Frank R, Cheng YJ, Narayan KV, Gregg EW. Trends in nutrient intake among adults with diabetes in the United States: 1988-2004. J Acad Nutr Diet. 2009;109(7):1173–1178.
18.
Zurück zum Zitat Zipf G, Chiappa M, Porter KS, Ostchega Y, Lewis BG, Dostal J. Health and nutrition examination survey plan and operations, 1999-2010. Vital Health Stat. 2013;1(56):10–22. Zipf G, Chiappa M, Porter KS, Ostchega Y, Lewis BG, Dostal J. Health and nutrition examination survey plan and operations, 1999-2010. Vital Health Stat. 2013;1(56):10–22.
19.
Zurück zum Zitat Parsons VL, Moriarity CL, Jonas K, Moore TF, Davis KE, Tompkins L. Design and estimation for the national health interview survey, 2006-2015. Vital Health Stat. 2014;2(165):1–53. Parsons VL, Moriarity CL, Jonas K, Moore TF, Davis KE, Tompkins L. Design and estimation for the national health interview survey, 2006-2015. Vital Health Stat. 2014;2(165):1–53.
21.
Zurück zum Zitat Johnson CL, Paulose-Ram R, Ogden CL, et al. National health and nutrition examination survey. Analytic guidelines, 1999-2010. Vital Health Stat 2. 2013(161):1–24. Johnson CL, Paulose-Ram R, Ogden CL, et al. National health and nutrition examination survey. Analytic guidelines, 1999-2010. Vital Health Stat 2. 2013(161):1–24.
22.
Zurück zum Zitat Ingram D, Malec D, Makuc D, et al. National Center for Health Statistics Guidelines for Analysis of Trends. Vital Health Stat. 2018;2(179):1–71. Ingram D, Malec D, Makuc D, et al. National Center for Health Statistics Guidelines for Analysis of Trends. Vital Health Stat. 2018;2(179):1–71.
23.
Zurück zum Zitat Gregg EW, Hora I, Benoit SR. Resurgence in Diabetes-Related Complications. JAMA. 2019;321(19):1867–1868.CrossRef Gregg EW, Hora I, Benoit SR. Resurgence in Diabetes-Related Complications. JAMA. 2019;321(19):1867–1868.CrossRef
24.
Zurück zum Zitat Evert AB, Boucher JL, Cypress M, et al. Nutrition therapy recommendations for the management of adults with diabetes. Diabetes Care. 2014;37(Supplement 1):S120-S143.CrossRef Evert AB, Boucher JL, Cypress M, et al. Nutrition therapy recommendations for the management of adults with diabetes. Diabetes Care. 2014;37(Supplement 1):S120-S143.CrossRef
25.
Zurück zum Zitat Ley SH, Hamdy O, Mohan V, Hu FB. Prevention and management of type 2 diabetes: dietary components and nutritional strategies. Lancet. 2014;383(9933):1999–2007.CrossRef Ley SH, Hamdy O, Mohan V, Hu FB. Prevention and management of type 2 diabetes: dietary components and nutritional strategies. Lancet. 2014;383(9933):1999–2007.CrossRef
26.
Zurück zum Zitat Ajala O, English P, Pinkney J. Systematic review and meta-analysis of different dietary approaches to the management of type 2 diabetes. Am J Clin Nutr. 2013;97(3):505–516.CrossRef Ajala O, English P, Pinkney J. Systematic review and meta-analysis of different dietary approaches to the management of type 2 diabetes. Am J Clin Nutr. 2013;97(3):505–516.CrossRef
27.
Zurück zum Zitat Ahola A, Groop PH. Barriers to self-management of diabetes. Diabet Med. 2013;30(4):413–420.CrossRef Ahola A, Groop PH. Barriers to self-management of diabetes. Diabet Med. 2013;30(4):413–420.CrossRef
28.
Zurück zum Zitat Nagelkerk J, Reick K, Meengs L. Perceived barriers and effective strategies to diabetes self-management. J Adv Nurs. 2006;54(2):151–158.CrossRef Nagelkerk J, Reick K, Meengs L. Perceived barriers and effective strategies to diabetes self-management. J Adv Nurs. 2006;54(2):151–158.CrossRef
29.
Zurück zum Zitat Lianov L, Johnson M. Physician competencies for prescribing lifestyle medicine. JAMA. 2010;304(2):202–203.CrossRef Lianov L, Johnson M. Physician competencies for prescribing lifestyle medicine. JAMA. 2010;304(2):202–203.CrossRef
30.
Zurück zum Zitat Kahan S, Manson JE. Nutrition counseling in clinical practice: how clinicians can do better. JAMA. 2017;318(12):1101–1102.CrossRef Kahan S, Manson JE. Nutrition counseling in clinical practice: how clinicians can do better. JAMA. 2017;318(12):1101–1102.CrossRef
31.
Zurück zum Zitat Vijan S, Stuart N, Fitzgerald J, et al. Barriers to following dietary recommendations in Type 2 diabetes. Diabet Med. 2005;22(1):32–38.CrossRef Vijan S, Stuart N, Fitzgerald J, et al. Barriers to following dietary recommendations in Type 2 diabetes. Diabet Med. 2005;22(1):32–38.CrossRef
32.
Zurück zum Zitat Booth AO, Lowis C, Dean M, Hunter SJ, McKinley MC. Diet and physical activity in the self-management of type 2 diabetes: barriers and facilitators identified by patients and health professionals. Prim Health Care Res Dev. 2013;14(3):293–306.CrossRef Booth AO, Lowis C, Dean M, Hunter SJ, McKinley MC. Diet and physical activity in the self-management of type 2 diabetes: barriers and facilitators identified by patients and health professionals. Prim Health Care Res Dev. 2013;14(3):293–306.CrossRef
33.
Zurück zum Zitat Colberg SR, Sigal RJ, Yardley JE, et al. Physical activity/exercise and diabetes: a position statement of the American Diabetes Association. Diabetes Care. 2016;39(11):2065–2079.CrossRef Colberg SR, Sigal RJ, Yardley JE, et al. Physical activity/exercise and diabetes: a position statement of the American Diabetes Association. Diabetes Care. 2016;39(11):2065–2079.CrossRef
34.
Zurück zum Zitat UK Prospective Diabetes Study Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352(9131):854–865.CrossRef UK Prospective Diabetes Study Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352(9131):854–865.CrossRef
35.
Zurück zum Zitat UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998;317(7160):703.CrossRef UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998;317(7160):703.CrossRef
36.
Zurück zum Zitat Brunström M, Carlberg B. Effect of antihypertensive treatment at different blood pressure levels in patients with diabetes mellitus: systematic review and meta-analyses. BMJ. 2016;352:i717.CrossRef Brunström M, Carlberg B. Effect of antihypertensive treatment at different blood pressure levels in patients with diabetes mellitus: systematic review and meta-analyses. BMJ. 2016;352:i717.CrossRef
37.
Zurück zum Zitat UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352(9131):837–853.CrossRef UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352(9131):837–853.CrossRef
38.
Zurück zum Zitat Emdin CA, Rahimi K, Neal B, Callender T, Perkovic V, Patel A. Blood pressure lowering in type 2 diabetes: a systematic review and meta-analysis. JAMA. 2015;313(6):603–615.CrossRef Emdin CA, Rahimi K, Neal B, Callender T, Perkovic V, Patel A. Blood pressure lowering in type 2 diabetes: a systematic review and meta-analysis. JAMA. 2015;313(6):603–615.CrossRef
39.
Zurück zum Zitat Kearney P, Blackwell L, Collins R, et al. Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Lancet. 2008;371(9607):117–125.CrossRef Kearney P, Blackwell L, Collins R, et al. Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Lancet. 2008;371(9607):117–125.CrossRef
40.
Zurück zum Zitat Kantor ED, Rehm CD, Haas JS, Chan AT, Giovannucci EL. Trends in prescription drug use among adults in the United States from 1999-2012. JAMA. 2015;314(17):1818–1830.CrossRef Kantor ED, Rehm CD, Haas JS, Chan AT, Giovannucci EL. Trends in prescription drug use among adults in the United States from 1999-2012. JAMA. 2015;314(17):1818–1830.CrossRef
41.
Zurück zum Zitat Zelniker TA, Wiviott SD, Raz I, et al. Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Major Adverse Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus: Systematic Review and Meta-Analysis of Cardiovascular Outcomes Trials. Circulation. 2019;139(17):2022–2031.CrossRef Zelniker TA, Wiviott SD, Raz I, et al. Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Major Adverse Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus: Systematic Review and Meta-Analysis of Cardiovascular Outcomes Trials. Circulation. 2019;139(17):2022–2031.CrossRef
Metadaten
Titel
Trends in Diabetes Management Among US Adults: 1999–2016
verfasst von
Michael Fang, PhD
Publikationsdatum
01.05.2020
Verlag
Springer International Publishing
Erschienen in
Journal of General Internal Medicine / Ausgabe 5/2020
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-019-05587-2

Weitere Artikel der Ausgabe 5/2020

Journal of General Internal Medicine 5/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Chronisches Koronarsyndrom: Gefahr von Hospitalisierung wegen Herzinsuffizienz

06.05.2024 Herzinsuffizienz Nachrichten

Obwohl ein rezidivierender Herzinfarkt bei chronischem Koronarsyndrom wahrscheinlich die Hauptsorge sowohl der Patienten als auch der Ärzte ist, sind andere Ereignisse womöglich gefährlicher. Laut einer französischen Studie stellt eine Hospitalisation wegen Herzinsuffizienz eine größere Gefahr dar.

Vorhofflimmern bei Jüngeren gefährlicher als gedacht

06.05.2024 Vorhofflimmern Nachrichten

Immer mehr jüngere Menschen leiden unter Vorhofflimmern. Betroffene unter 65 Jahren haben viele Risikofaktoren und ein signifikant erhöhtes Sterberisiko verglichen mit Gleichaltrigen ohne die Erkrankung.

„Restriktion auf vier Wochen Therapie bei Schlaflosigkeit ist absurd!“

06.05.2024 Insomnie Nachrichten

Chronische Insomnie als eigenständiges Krankheitsbild ernst nehmen und adäquat nach dem aktuellen Forschungsstand behandeln: Das forderte der Schlafmediziner Dr. Dieter Kunz von der Berliner Charité beim Praxis Update.

GLP-1-Rezeptoragonisten und SGLT-2-Hemmer: zusammen besser

06.05.2024 Typ-2-Diabetes Nachrichten

Immer häufiger wird ein Typ-2-Diabetes sowohl mit einem GLP-1-Rezeptor-Agonisten als auch mit einem SGLT-2-Inhibitor behandelt. Wie sich das verglichen mit den Einzeltherapien auf kardiovaskuläre und renale Komplikationen auswirkt, wurde anhand von Praxisdaten aus Großbritannien untersucht.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.